Compugen (CGEN) Gross Profit Growth (1y) (2010 - 2026)
Compugen (CGEN) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Compugen |
189.59 Mn |
97.83 Mn |
352,000.00 |
403.45% |
| Date | Value |
|---|
| Mar 31, 2026 |
403.45% |
| Dec 31, 2025 |
-99.99% |
| Sep 30, 2025 |
-98.22% |
| Jun 30, 2025 |
-107.92% |
| Mar 31, 2025 |
-125.38% |
| Dec 31, 2024 |
-97.47% |
| Dec 31, 2023 |
382.07% |
| Dec 31, 2016 |
-99.75% |
| Sep 30, 2016 |
-100.00% |
| Jun 30, 2016 |
446.67% |
| Mar 31, 2016 |
-90.84% |
| Dec 31, 2015 |
30.76% |
| Sep 30, 2015 |
2,865,816.07% |
| Jun 30, 2015 |
-93.21% |
| Mar 31, 2015 |
-90.48% |
| Dec 31, 2014 |
476.68% |
| Sep 30, 2014 |
681.60% |
| Jun 30, 2014 |
1,882.26% |
| Mar 31, 2014 |
11,366.67% |
| Dec 31, 2013 |
2,938.24% |
